Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project

MLA

McKoy, June M., et al. “Gemtuzumab Ozogamicin-Associated Sinusoidal Obstructive Syndrome (SOS): An Overview from the Research on Adverse Drug Events and Reports (RADAR) Project.” Leukemia Research, vol. 31, no. 5, May 2007, pp. 599–604. EBSCOhost, https://doi.org/10.1016/j.leukres.2006.07.005.

APA

McKoy, J. M., Angelotta, C., Bennett, C. L., Tallman, M. S., Wadleigh, M., Evens, A. M., Kuzel, T. M., Trifilio, S. M., Raisch, D. W., Kell, J., DeAngelo, D. J., & Giles, F. J. (2007). Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project. Leukemia Research, 31(5), 599–604. https://doi.org/10.1016/j.leukres.2006.07.005

Chicago

McKoy, June M., Cara Angelotta, Charles L. Bennett, Martin S. Tallman, Martha Wadleigh, Andrew M. Evens, Timothy M. Kuzel, et al. 2007. “Gemtuzumab Ozogamicin-Associated Sinusoidal Obstructive Syndrome (SOS): An Overview from the Research on Adverse Drug Events and Reports (RADAR) Project.” Leukemia Research 31 (5): 599–604. doi:10.1016/j.leukres.2006.07.005.